Is there a generic for Dichlorphenamide?

Yes. The FDA Orange Book lists 2 approved generic (ANDA) applications for Dichlorphenamide, referencing the brand DARANIDE. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Dichlorphenamide?

DARANIDE (NDA 011366, XERIS) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Dichlorphenamide are approved?

Dichlorphenamide is approved in the following dosage form: tablet.

FDA Orange Book · active-ingredient family

Dichlorphenamide

Dichlorphenamide is approved as 1 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:DARANIDE · NDA 011366

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · tablet

Product	Applicant	Application	TE	Approved
DARANIDERLD×2	XERIS	NDA 011366	—	Approved Prior to Jan 1, 1982

Generic (ANDA) products (2)

Product	Applicant	Application	TE	Approved
DICHLORPHENAMIDE	RISING	ANDA 218783	AB	Nov 18, 2025
ORMALVI	TORRENT	ANDA 215924	AB	Dec 29, 2022

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Dichlorphenamide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo